F.D.A. Panel’s Action Could Open Way to Lower-Cost Biologics
The group is expected to recommend approval of a cheaper copy of a special cancer drug, which could lead to generic copies of expensive medications. [Source]
Publication Date:Origin: nytimes.com
Category: United States
Topics: medications, expensive, copies, generic, could, which, cancer, special, cheaper, approval, recommend, expected, group, Biologics, Lower-Cost, Could, Action, Panel’s